par Rosoux, Adeline;Ocak, Sebahat;Pauwels, Patrick;Duplaquet, Fabrice;D'Haene, Nicky ;Weynand, Birgit;Delos, Monique;Menon, Roopika;Heukamp, Lukas Carl Arl L.C.;Thunnissen, Erik
Référence Lung cancer, 98, page (118-121)
Publication Publié, 2016-08
Référence Lung cancer, 98, page (118-121)
Publication Publié, 2016-08
Article révisé par les pairs
Résumé : | We report a case of crizotinib effectiveness in a heavily pretreated patient with a metastatic NSCLC initially considered IHC-positive and FISH-negative for ALK rearrangement. After repeated analyses of tumor samples, borderline ALK FISH-positivity (18.5% positive cells) was demonstrated. |